Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, Par Value $0.001 Per Share
-
Shares outstanding
-
47M
-
Number of holders
-
252
-
Total shares
-
47.7M
-
Shares change
-
-276K
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
-$4.14M
-
Put/Call ratio
-
0.43
-
Number of buys
-
113
-
Number of sells
-
-126
-
Price
-
$33.74
Significant Holders of Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) as of Q4 2023
258 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share as of Q4 2023.
Pacira BioSciences, Inc. - Common Stock, Par Value $0.001 Per Share (PCRX) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
.
Largest 10 shareholders include BlackRock Inc. (8.11M shares), VANGUARD GROUP INC (5.1M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2.08M shares), STATE STREET CORP (1.94M shares), RENAISSANCE TECHNOLOGIES LLC (1.72M shares), DIMENSIONAL FUND ADVISORS LP (1.41M shares), MACQUARIE GROUP LTD (1.38M shares), Stephens Investment Management Group LLC (1.32M shares), Vestal Point Capital, LP (1.2M shares), and Clearbridge Investments, LLC (1.15M shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.